[EN] METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION<br/>[FR] LES MÉTABOLITES DE LA MÉTHIONINE PRÉDISENT LA PROGRESSION D'UN CANCER AGRESSIF
申请人:CEDARS SINAI MEDICAL CENTER
公开号:WO2014026157A2
公开(公告)日:2014-02-13
The invention relates to the use of enzymes, nanorods, and nanoelectronic devices to detect cysteine level in a patient sample and relates to the use of the detected cysteine level to predict cancer recurrence in the patient and to prescribe and/or administer an appropriate therapy to a subject. The invention is directed to systems and methods of detecting cysteine level in a sample from a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention is directed to systems and methods of predicting the probability of a recurrence of a cancer in a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention further comprises prescribing and/or administering an appropriate therapy to a subject based on the predicted probability of recurrence.